Fig. 3.

Cancer stem cell targeted cancer therapy versus conventional cancer therapy. Conventional cancer therapy targets tumor cells in general, but does not selectively kill CSCs. Therefore, there is a high chance for relapse. When the therapeutic approach is targeted towards CSCs, these tumor-initiating cells are killed. As a result, the tumor loses the capacity to regenerate and, thus, is more unlikely to recur